Soligenix Inc. (SNGX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $7.50M
Last updated: Nov 17, 2026 at 11:02 AM ET
Soligenix Inc. (SNGX) Earnings: Report Dates and Results
Soligenix (SNGX) is expected to report earnings on Mar 29, 2027. In the quarter ended Sep 30, 2026, Soligenix reported EPS of -$0.05, above the -$0.12 estimate. It beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
SNGX has an expected report date of Mar 29, 2027.
Earnings History
Of the 40 quarters below that had an estimate, SNGX beat 25, missed 14 and matched 1. The widest gap in the table came in the quarter ended Dec 31, 2022, when EPS landed 308.93% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.05 | -$0.12 | N/A | +58.33% | Beat | N/A | 1 | 1 up, 0 down | Nov 6, 2026 | N/A |
| Jun 30, 2026 | -$0.12 | -$0.22 | N/A | +45.45% | Beat | N/A | 1 | 1 up, 0 down | Aug 7, 2026 | N/A |
| Mar 31, 2026 | -$0.28 | -$0.30 | N/A | +6.67% | Beat | N/A | 1 | 0 up, 0 down | Apr 3, 2026 | N/A |
| Sep 30, 2025 | -$0.58 | -$0.48 | -$0.48 - -$0.48 | -20.83% | Miss | N/A | 1 | 0 up, 0 down | Nov 7, 2025 | N/A |
| Jun 30, 2025 | -$0.82 | -$1.05 | -$1.05 - -$1.05 | +21.90% | Beat | N/A | 1 | 0 up, 0 down | Aug 14, 2025 | N/A |
| Mar 31, 2025 | -$1.06 | -$0.67 | N/A | -58.21% | Miss | N/A | N/A | 0 up, 0 down | May 9, 2025 | N/A |
| Dec 31, 2024 | -$1.14 | -$1.56 | -$1.56 - -$1.56 | +26.92% | Beat | N/A | 1 | 0 up, 0 down | Mar 21, 2025 | $6352 |
| Sep 30, 2024 | -$0.78 | -$1.69 | N/A | +53.85% | Beat | N/A | 1 | 0 up, 0 down | Nov 8, 2024 | N/A |
| Jun 30, 2024 | -$1.31 | -$1.77 | -$2.11 - -$1.44 | +25.99% | Beat | N/A | 2 | 0 up, 0 down | Aug 9, 2024 | $2342 |
| Mar 31, 2024 | -$0.18 | -$0.19 | -$0.20 - -$0.18 | +5.26% | Beat | N/A | 2 | 1 up, 0 down | May 10, 2024 | $117029 |
| Dec 31, 2023 | -$2.56 | -$3.12 | -$3.20 - -$3.04 | +17.95% | Beat | N/A | 2 | 0 up, 0 down | Mar 15, 2024 | $244812 |
| Sep 30, 2023 | -$2.56 | -$4.64 | -$7.04 - -$2.24 | +44.83% | Beat | N/A | 2 | 0 up, 0 down | Nov 13, 2023 | $130440 |
| Jun 30, 2023 | -$3.52 | -$6.08 | N/A | +42.11% | Beat | N/A | 1 | 0 up, 0 down | Aug 21, 2023 | $206929 |
| Mar 31, 2023 | -$5.76 | -$20.00 | -$20.00 - -$20.00 | +71.20% | Beat | N/A | 1 | 0 up, 0 down | May 15, 2023 | $257178 |
| Dec 31, 2022 | -$4.58 | -$1.12 | -$1.28 - -$1.05 | -308.93% | Miss | N/A | 2 | 0 up, 1 down | Mar 31, 2023 | $366068 |
| Sep 30, 2022 | -$19.20 | -$21.60 | -$23.99 - -$19.19 | +11.11% | Beat | N/A | 2 | 0 up, 0 down | Nov 10, 2022 | $166140 |
| Jun 30, 2022 | -$13.58 | -$24.00 | N/A | +43.42% | Beat | N/A | 3 | 0 up, 0 down | Aug 12, 2022 | $228640 |
| Mar 31, 2022 | -$24.62 | -$19.20 | N/A | -28.23% | Miss | N/A | 2 | 0 up, 0 down | May 13, 2022 | $188063 |
| Dec 31, 2021 | -$1.65 | -$1.20 | -$1.35 - -$0.90 | -37.50% | Miss | N/A | 3 | 0 up, 0 down | Mar 29, 2022 | $128060 |
| Sep 30, 2021 | -$21.00 | -$19.20 | -$38.38 - -$19.19 | -9.38% | Miss | N/A | 2 | N/A | Nov 12, 2021 | $186198 |
| Jun 30, 2021 | -$12.00 | -$26.40 | -$31.18 - -$21.59 | +54.55% | Beat | N/A | 3 | N/A | Aug 13, 2021 | $214824 |
| Mar 31, 2021 | -$15.96 | -$16.80 | N/A | +5.00% | Beat | N/A | 3 | N/A | May 17, 2021 | $295186 |
| Dec 31, 2020 | -$2.40 | -$1.20 | -$1.65 - -$0.75 | -100.00% | Miss | N/A | 5 | N/A | Mar 30, 2021 | $635263 |
| Sep 30, 2020 | -$14.71 | -$33.60 | N/A | +56.22% | Beat | N/A | 3 | N/A | Nov 12, 2020 | $507171 |
| Jun 30, 2020 | -$25.08 | -$38.40 | N/A | +34.69% | Beat | N/A | 4 | N/A | Aug 14, 2020 | $292461 |
| Mar 31, 2020 | -$26.81 | -$36.00 | N/A | +25.53% | Beat | N/A | 3 | N/A | May 15, 2020 | $924552 |
| Dec 31, 2019 | -$2.10 | -$1.99 | -$2.40 - -$1.65 | -5.53% | Miss | N/A | 4 | N/A | Mar 30, 2020 | $685260 |
| Sep 30, 2019 | -$33.60 | -$33.60 | N/A | 0.00% | In line | N/A | 3 | N/A | Nov 12, 2019 | $1.25M |
| Jun 30, 2019 | -$28.80 | -$33.60 | -$35.98 - -$31.18 | +14.29% | Beat | N/A | 3 | N/A | Aug 13, 2019 | $1.54M |
| Mar 31, 2019 | -$21.60 | $40.80 | N/A | -152.94% | Miss | N/A | 2 | N/A | May 14, 2019 | $1.14M |
| Dec 31, 2018 | -$2.70 | -$2.25 | N/A | -20.00% | Miss | N/A | 3 | N/A | Mar 26, 2019 | $1.01M |
| Sep 30, 2018 | -$26.40 | -$24.00 | N/A | -10.00% | Miss | N/A | N/A | N/A | Nov 9, 2018 | $1.38M |
| Jun 30, 2018 | -$43.20 | -$48.00 | N/A | +10.00% | Beat | N/A | 1 | N/A | Aug 8, 2018 | $1.73M |
| Mar 31, 2018 | -$0.27 | -$0.25 | N/A | -8.00% | Miss | N/A | 1 | N/A | May 11, 2018 | $1.12M |
| Dec 31, 2017 | -$64.80 | -$69.60 | N/A | +6.90% | Beat | N/A | N/A | N/A | Mar 15, 2018 | $1.29M |
| Sep 30, 2017 | -$40.80 | -$88.80 | N/A | +54.05% | Beat | N/A | N/A | N/A | Nov 6, 2017 | $1.82M |
| Jun 30, 2017 | -$98.40 | -$77.60 | N/A | -26.80% | Miss | N/A | N/A | N/A | Aug 11, 2017 | $990971 |
| Mar 31, 2017 | -$4.80 | -$6.75 | N/A | +28.89% | Beat | N/A | N/A | N/A | May 11, 2017 | $1.33M |
| Dec 31, 2016 | -$563.47 | -$165.60 | N/A | -240.26% | Miss | N/A | N/A | N/A | Mar 27, 2017 | $1.70M |
| Sep 30, 2016 | -$104.69 | -$208.80 | N/A | +49.86% | Beat | N/A | N/A | N/A | Nov 10, 2016 | $2.96M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$2.46, after -$3.41 the year before. It was -$861.48 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$2.46 | N/A |
| Dec 31, 2024 | -$3.41 | N/A |
| Dec 31, 2023 | -$14.40 | N/A |
| Dec 31, 2022 | -$61.98 | N/A |
| Dec 31, 2021 | -$50.61 | N/A |
| Dec 31, 2020 | -$69.00 | N/A |
| Dec 31, 2019 | -$86.10 | N/A |
| Dec 31, 2018 | -$72.57 | N/A |
| Dec 31, 2017 | -$208.80 | N/A |
| Dec 31, 2016 | -$861.48 | N/A |
Frequently Asked Questions About SNGX
When is Soligenix's next earnings date?
Soligenix's next earnings report is expected for Mar 29, 2027.
Did SNGX beat earnings estimates last quarter?
Yes. Soligenix reported EPS of -$0.05 for the quarter ended Sep 30, 2026, above the -$0.12 estimate, a 58.33% surprise.
What EPS do analysts expect from SNGX next quarter?
The consensus EPS estimate for Soligenix for the quarter ending Dec 31, 2026 is -$0.09 from 4 analysts, with estimates from -$0.10 to -$0.07.
How often does SNGX beat earnings estimates?
Soligenix beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate, with an average surprise of +16.76%.
SNGX pages: Overview, Earnings, Forecast, Financials, Competitors